New Constellations 2019 | Page 60

SURGERY • CONTINUED FROM PREVIOUS PAGE Better than a diabetic wound that heals But it didn’t work on diabetic wounds. is one that never happens. Dr. Liechty and At the same time, Dr. Liechty’s research team was working with microRNAs, non-coding RNAs that regulate gene expression. They’d been used in cancer research, but Dr. Liechty’s team was the first to use them to recreate the inflammatory conditions of the womb by shutting down pro- inflammatory interleukins 6 and 8. his team developed a nanosilk serum that strengthens the skin. can’t feel it when you’re injured, and then there’s a bunch of bacteria sitting around.” “It creates an environment so inflammatory, so hostile,” says University of Colorado School of Medicine regenerative biologist Carlos Zgheib, PhD, a researcher in Dr. Liechty’s lab, “that cells are not going to be able to proliferate and close that wound.” More than 30 million people in the U.S. have diabetes, and 20 percent of them have non-healing wounds. That’s on top of 84 million more with prediabetes. At last count, the rate of diabetic amputations was around 73,000 a year. “So the question is,” says Dr. Liechty, “how do you fetalize the adult?” difference in the fetal inflammatory response. From an evolutionary perspective, that would make sense. Once you’re out of the womb, it’s about getting the wound closed before you die of infection.” K E N N E T H L I E C H T Y, M D Pediatric Thoracic and Fetal Surgeon, The Sandy Wolf Chair in Maternal Fetal Surgery 58 A fetus’s priority is to grow and make new tissue. They don’t need a big, brisk inflammatory response against the outside world’s many agents of harm. “Once you’re out of the womb,” he says, “it’s about getting the wound closed before you die of infection.” Good if you’re a hunter-gatherer, not so good if you have, say, a chronically inflammatory condition. Even worse if you have one like diabetes, which also saps the immune system, weakens skin, damages nerves and, because it often correlates with obesity, puts extra pressure on feet. “The bacterial load of diabetic skin is 40 times higher than healthy skin,” says Dr. Liechty. “So you have skin that’s weaker and easier to injure, you A two-pronged approach to healing When the skin breaks, macrophages invade the area and start cranking out reactive oxygen species, volatile compounds that damage cells around them by stripping elements of their DNA. That damages microbes, but it also damages the surrounding tissue. Materials engineer and biochemist Sudipta Seal, PhD, Dr. Liechty’s collaborator at the University of Central Florida, figured out years ago that a rare earth metal called cerium oxide could bind reactive oxygen species. At the time it was used primarily in catalytic converters and jewelry polish. Dr. Seal observed that, in the form of nanoparticles known as nanoceria, it could slow the progression of macular degeneration. Drs. Liechty and Zgheib discovered it could promote wound healing. The problem was that oxidative stress signals more inflammation. Diabetic wounds were so persistent that, as soon as the microRNA wore off, oxidative stress would stoke the inflammation again. It was when they combined the two, conjugating the microRNA to the nanoceria particle, that everything changed. “It was like a miracle,” says Dr. Zgheib. “In the animal model, we corrected diabetic healing to the normal rate.” The discovery earned Dr. Zgheib the American College of Surgeons’ Excellence in Research Award last year, with publication in that group’s journal. The research team hopes to start phase 1 clinical trials this year. “You’d worry maybe it’s just a superficial closure, not functionally healed,” adds Dr. Liechty. “We’ve shown it’s actually better. Diabetic skin at baseline is weak. When we test our wound closures, they’re stronger.” Engineering the delivery In the meantime, they’re refining how the combination of nanoceria and microRNA, which Dr. Zgheib calls “the conjugate,” gets into the wound. Initially they injected it. That’s fine for animal studies, but they knew sticking needles into open wounds would be a tall order for actual patients. NEW CONSTELLATIONS 59